CTA
EXAS

Carillon Tower Advisers’s Exact Sciences EXAS Stock Holding History

Carillon Tower Advisers’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-788,319
Closed -$44.1M – 469
2020
Q1 		$44.1M Hold
788,319
– – 0.43% 69
2019
Q4 		$72.9M Sell
788,319
-41,397
-5% -$3.64M 0.49% 58
2019
Q3 		$75M Buy
829,716
+100
+0% +$11.4K 0.52% 44
2019
Q2 		$97.9M Sell
829,616
-100
-0% -$10.1K 0.67% 19
2019
Q1 		$71.9M Buy
829,716
+51,526
+7% +$4.39M 0.51% 44
2018
Q4 		$49.1M Sell
778,190
-132,167
-15% -$9.07M 0.42% 68
2018
Q3 		$71M Buy
910,357
+269,419
+42% +$17.6M 0.51% 49
2018
Q2 		$38.3M Sell
640,938
-620,578
-49% -$33.4M 0.3% 120
2018
Q1 		$48.9M Hold
1,261,516
– – 0.38% 78
2017
Q4 		$66.3M Buy
+1,261,516
New +$67.4M 0.71% 30

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Carillon Tower Advisers's EXAS Position: Q2 2020 in Review

Carillon Tower Advisers sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 788,319 shares — an estimated $44.1M sold.

Carillon Tower Advisers first reported a position in EXAS in Q4 2017 and held it in 10 quarters. The position peaked at $97.9M in Q2 2019. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

  • Carillon Tower Advisers reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 788,319 Exact Sciences shares in Q2 2020, an estimated $44.1M.
  • Carillon Tower Advisers first reported a position in Exact Sciences in Q4 2017 and held it in 10 quarters.
  • Carillon Tower Advisers's Exact Sciences position peaked at $97.9M in Q2 2019.
  • 513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.